Stockreport

GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide

GoodRx Holdings, Inc. - Class A  (GDRX) 
PDF Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRxBrief Summary:GoodRx is expanding access to the newly FDA-approved oral GLP-1 me [Read more]